Law: Psychedelic Drugs for Mental Health Disorders: Clinical and Legal Issues
Law: Psychedelic Drugs for Mental Health Disorders: Clinical and Legal Issues is organized by University of Connecticut (UConn) School of Pharmacy.
Released: April 28, 2022
Expires: April 28, 2025
Learning Objectives:
• Describe the important features of post-traumatic stress disorder (PTSD) and major depressive disorder (MDD) with commonly employed non-pharmacologic and pharmacologic treatments • Identify the pharmacologic features of MDMA and psilocybin and clinical trial results when applied to patients with mental health disorders
• Describe legal barriers to using psychedelics in patients with mental health disorders and ways to circumvent them at a national or state level
Additional details will be posted as soon as information is available.
